Literature DB >> 10884898

Critical analysis and comparison of the side-effect and safety profiles of the new antipsychotics.

T R Barnes1, M A McPhillips.   

Abstract

Mesh:

Substances:

Year:  1999        PMID: 10884898

Source DB:  PubMed          Journal:  Br J Psychiatry Suppl        ISSN: 0960-5371


× No keyword cloud information.
  15 in total

Review 1.  Pharmacokinetic factors in the adverse cardiovascular effects of antipsychotic drugs.

Authors:  Candace S Brown; Richard G Farmer; Judith E Soberman; Samantha F Eichner
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

2.  Antipsychotic-induced movement disorders: evaluation and treatment.

Authors:  Maju Mathews; Sylvia Gratz; Babatunde Adetunji; Vinu George; Manu Mathews; Biju Basil
Journal:  Psychiatry (Edgmont)       Date:  2005-03

3.  Movement disorders induced by antipsychotic drugs: implications of the CATIE schizophrenia trial.

Authors:  Stanley N Caroff; Irene Hurford; Janice Lybrand; E Cabrina Campbell
Journal:  Neurol Clin       Date:  2011-02       Impact factor: 3.806

Review 4.  Cardiovascular Disease in Clozapine-Treated Patients: Evidence, Mechanisms and Management.

Authors:  Kathlyn J Ronaldson
Journal:  CNS Drugs       Date:  2017-09       Impact factor: 5.749

Review 5.  Biotransformation of post-clozapine antipsychotics: pharmacological implications.

Authors:  S Caccia
Journal:  Clin Pharmacokinet       Date:  2000-05       Impact factor: 6.447

Review 6.  Clozapine: in prevention of suicide in patients with schizophrenia or schizoaffective disorder.

Authors:  Antona Wagstaff; Caroline Perry
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

Review 7.  Cardiovascular adverse effects of antipsychotic drugs.

Authors:  N A Buckley; P Sanders
Journal:  Drug Saf       Date:  2000-09       Impact factor: 5.606

8.  Influence of aripiprazole, risperidone, and amisulpride on sensory and sensorimotor gating in healthy 'low and high gating' humans and relation to psychometry.

Authors:  Philipp A Csomor; Katrin H Preller; Mark A Geyer; Erich Studerus; Theodor Huber; Franz X Vollenweider
Journal:  Neuropsychopharmacology       Date:  2014-05-07       Impact factor: 7.853

Review 9.  Third generation antipsychotic drugs: partial agonism or receptor functional selectivity?

Authors:  Richard B Mailman; Vishakantha Murthy
Journal:  Curr Pharm Des       Date:  2010       Impact factor: 3.116

10.  Orthostatic hypotensive effect of antipsychotic drugs in Wistar rats by in vivo and in vitro studies of alpha1-adrenoceptor function.

Authors:  Z Nourian; T Mow; D Muftic; S Burek; M L Pedersen; J Matz; M J Mulvany
Journal:  Psychopharmacology (Berl)       Date:  2008-06-10       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.